Tuning the Upper Critical Solution Temperature of the Polystyrene-Terpineol System toward a Low-Temperature Membrane Formation by Sulaiman Dhameri (22048528)

Subjects:

Stereotactic injection of AAV-miR-129-5p attenuated microglia activation in depressed mice. by Qiaozhen Qin (13159201)

Subjects:

Stereotactic injection of AAV-miR-129-5p suppressed astrocyte activation in depressed mice. by Qiaozhen Qin (13159201)

Subjects:

Odds ratio (OR) for depression (HADS-D>=8) with 95% confidence interval (CI). Analyses are run using the weighted survey design on the sub-sample with non-missing for all included... by Maria Lage Barca (4515385)

Subjects:

Relationship between miR-129-5p and Mysm1 in depressed mice. by Qiaozhen Qin (13159201)

Subjects:

PCAIs disrupt actin filaments in NCI-H23 cells. by Matthew D. Gregory (19929096)

PCAIs suppress and disrupt the levels of vinculin punctates in NCI-H23 cells. by Matthew D. Gregory (19929096)

Overexpression of miR-129-5p alleviated depression-like behaviors by increasing ATP content. by Qiaozhen Qin (13159201)

Subjects:

Overexpression of miR-129-5p alleviated the depressive-like phenotypes of CRS and LPS treated mice. by Qiaozhen Qin (13159201)

Subjects:

PCAIs induce apoptosis in NCI-H23 cells. by Matthew D. Gregory (19929096)

AZ10606120 treatment significantly increased cytotoxicity and reduced cell number in a dose-dependent manner. by Matthew Drill (22258391)

“…Cell numbers were significantly decreased in cells after treatment with AZ10606120 (50µM) compared to both temozolomide (TMZ; 50µM) treatment and untreated controls. …”

Correlations between significantly different microbiota and metabolites. by Bhuripit Saraphol (20855573)

Subjects:

Periodic Open Cellular Structures with Streamlined Elliptical Struts for the Intensification of Mass Transfer-Limited Catalytic Reactors by Claudio Ferroni (10972436)

Subjects:

Blood Pressure and LDL-C During Follow-up. by Karl Ingard (22582091)

Subjects:

Median EQ-5D-3L index values during 5 years of follow-up. by Karl Ingard (22582091)

Subjects:

Baseline Characteristics of Included Patients. by Karl Ingard (22582091)

Subjects:

Subgroup Analysis of the Occurrence of Secondary Endpoints. by Karl Ingard (22582091)

Subjects:

Study flow chart. by Karl Ingard (22582091)

Subjects:

Kaplan-Meier curve of the primary outcome. by Karl Ingard (22582091)

Subjects:

Number of Patients Who Reached the Primary and Secondary Endpoints During Follow-up. by Karl Ingard (22582091)

Subjects: